4//SEC Filing
MEDTOX SCIENTIFIC INC 4
Accession 0001140361-12-019226
CIK 0000739944operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:41 PM ET
Size
6.7 KB
Accession
0001140361-12-019226
Insider Transaction Report
Form 4
SCHOONOVER JAMES A
Vice President and CMO
Transactions
- Award
Common Stock
2012-04-03$17.37/sh+16,522$286,987→ 130,728 total - Award
Common Stock
2012-04-03$17.37/sh+1,295$22,494→ 132,023 total
Footnotes (2)
- [F1]Shares are attributable to a performance based non-qualified deferred compensation plan and are subject to vesting and a substantial risk of forfeiture. Shares have been acquired either in a private transaction or in the open market and are exempt under Rule 16b-3.
- [F2]Shares are attributable to a non-qualified deferred compensation plan and are subject to vesting and a substantial risk of forfeiture. Shares have been acquired either in a private transaction or in the open market and are exempt under Rule 16b-3.
Documents
Issuer
MEDTOX SCIENTIFIC INC
CIK 0000739944
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000739944
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:41 PM ET
- Size
- 6.7 KB